Utility of a Survey Instrument to Predict Benefit From a Novel Treatment for Vertical Heterophoria

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Binocular Vision DysfunctionVertical Heterophoria
Interventions
OTHER

Questionnaires and Optometrist Prism Challenge/Treatment

A Vertical Heterophoria Symptom Questionnaire (VHSQ) as well as Headache Disability Index (HDI) survey is used on all Emergency Department (ED) headache patients to assess medical history and symptom burden. Prism testing (or Prism Challenge) is performed by the study optometrist to identify those who have Vertical Heterophoria (VH). Prism Challenge is similar to prescription eyeglass testing, but with unique lenses that are meant to reduce strain on eyes that are misaligned. Follow-up questionnaires are then administered to assess any improvement in symptom burden.

Trial Locations (2)

48154

St. Mary Mercy Hospital, Livonia

48302

Vision Specialists of Michigan, Bloomfield Hills

All Listed Sponsors
collaborator

Trinity Health Michigan

OTHER

lead

Vision Specialists of Birmingham

OTHER

NCT01632787 - Utility of a Survey Instrument to Predict Benefit From a Novel Treatment for Vertical Heterophoria | Biotech Hunter | Biotech Hunter